ARCHIVES

Genentech’s Ferrara Selected for GM Award.

This article is from The Cancer Letter archive.

Vol. 32 No. 24 | June 23, 2006

Download PDF Visit The Full Archive

Related Articles

FDA Approves Xeloda For Colon Cancer; Phase III Data Not Reviewed By ODAC.

May 4, 2001

Advisors Approve Lung Screening Trial Testing Spiral CT Vs. X-Ray, For $200M.

November 23, 2001

FDA News: Consolidation Plan Designed For Savings

June 5, 1998

Nutrition Program Announcement Lists Suggested Areas For Research

September 22, 1978

House Committee Probes NCI $5.2 Billion Sole-Source Contract With SAIC-Frederick.

November 14, 2008

Basic Research Group Seeks $7.9 Billion For NIH, $1.7 For NCI

July 24, 1987